Dr. Daniel William Golden, MD

Dr. Golden practices at Rush University Medical Center in Chicago, Illinois, part of Rush System for Health.

Dr. Golden's NPI, 1174752588, was assigned on July 7, 2009. Dr. Golden graduated from University of Illinois College of Medicine - Chicago in 2007. Dr. Golden holds Illinois license 036132890.

Dr. Golden's primary practice is Rush University Medical Center, at 1653 West Congress Parkway, Chicago, IL 60612 in Cook County. The practice phone is (312) 942-5000.

Dr. Golden's primary practice is Rush University Medical Center in Chicago, Illinois, part of Rush System for Health. Dr. Golden is also affiliated with University of Chicago Medical Center. The medical group on file is Rush University Internists. Dmand AI also links Dr. Golden to 2 more hospitals, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Golden practices, 4 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Golden's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dr. Golden is board certified in radiation oncology by the American Board of Radiology. Dmand AI has Dr. Golden's licenses on file in 2 states: Illinois and California.

Dmand AI lists bladder cancer radiation, bone cancer radiation, brain cancer radiation, cancer radiation-upper GI, cervical cancer radiation, colorectal cancer radiation, head & neck cancer radiation and lung cancer radiation among the conditions Dr. Golden treats.

CMS data shows 1,286 Medicare services from Dr. Golden across 18 procedure codes in 2024, for 173 Medicare patients. Medicare paid $100,789 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 173 Medicare patients who saw Dr. Golden in 2024. The largest group is 65 to 74, with 77 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 26% are also on Medicaid. Their average risk score is 2.34, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Golden's median patient age at 72, with 42% women.

In 2024, Dr. Golden wrote 85 Medicare Part D claims for 34 patients. 87% of them were for generic drugs. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $499 in total drug cost. In 2023, CMS named 28 claims across 2 drugs.

Dr. Golden accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 92 papers to Dr. Golden, published from 2009 to 2024. 2019 was the busiest year, with 12. The most frequent topics are Radiation Oncology, Internship and Residency and Curriculum. Dr. Golden has published most often in Int J Radiat Oncol Biol Phys. Dr. Golden's most frequent co-authors are Anne R. McCall, MD, Steve Braunstein, MD, PhD and Emma Charlotte Fields, MD.

CMS Open Payments shows 2 general payments to Dr. Golden from 2 drug and device companies from 2017 to 2025. Food and beverage make up the largest share, 100% of the total. C. R. Bard, Inc. & Subsidiaries paid the most, $24.

Dr. Golden graduated from University of Illinois College of Medicine - Chicago in 2007.